Laurion Capital Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-10,800
Closed -$1.44M 1447
2018
Q4
$1.44M Sell
10,800
-198,200
-95% -$32.5M 0.03% 479
2018
Q3
$39.8M Buy
+209,000
New +$38.4M 0.39% 43
2017
Q2
Sell
-10,600
Closed -$2.53M 1995
2017
Q1
$2.53M Buy
10,600
+8,900
+524% +$2.07M 0.02% 558
2016
Q4
$357K Sell
1,700
-280,500
-99% -$58.1M ﹤0.01% 899
2016
Q3
$65M Buy
282,200
+98,800
+54% +$24.1M 0.61% 25
2016
Q2
$42.4M Buy
+183,400
New +$42.3M 0.66% 39
2016
Q1
Sell
-705,000
Closed -$220M 1215
2015
Q4
$220M Buy
705,000
+547,500
+348% +$163M 2.03% 6
2015
Q3
$42.8M Buy
+157,500
New +$48.4M 0.5% 49

Other funds holding AGN

Laurion Capital Management's AGN Position: Q2 2020 in Review

Laurion Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 1,163,966 shares — an estimated $206M sold.

Laurion Capital Management first reported a position in AGN in Q3 2014 and held it in 15 quarters. The position peaked at $206M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Laurion Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Laurion Capital Management sold 1,163,966 Allergan plc shares in Q2 2020, an estimated $206M.
  • Laurion Capital Management first reported a position in Allergan plc in Q3 2014 and held it in 15 quarters.
  • Laurion Capital Management's Allergan plc position peaked at $206M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Laurion Capital Management's 13F filing for Q2 2020, filed 14 Aug 2020.